“The earnings have been mixed. Given the valuations in the technology sector, I think it is causing portfolio managers to get a little nervous and take some profits.”
“This may well be another consequence of our use of antibiotics. It's another example of an organism that all of a sudden has gotten a lot meaner and nastier.”
“I'm not surprised. There's a lot of consolidation going on within the industry, and the promise of a new set of services, it will be interesting to see how this all plays out.”
